XML 46 R33.htm IDEA: XBRL DOCUMENT v3.22.4

STOCK-BASED COMPENSATION PLANS (Tables)

12 Months Ended

Dec. 31, 2022

STOCK-BASED COMPENSATION PLANS

Schedule of outstanding and exercisable number of options

As of December 31, 2022, the Company had the following stock options outstanding and exercisable:

​

​	​	​	​	​	​
​		Outstanding Number of Options		Exercisable Number of Options
​	​	(in thousands)	​	(in thousands)
Plan Category				​
2005 Stock Option Plan		211		​	211
2017 Stock Option Plan		582		​	346
Total		793	​	​	557

​

Summary of Black Scholes option pricing model to determine the fair value of stock option grants, using the following assumptions

During the year ended December 31, 2022, 0.2 million performance based stock option awards were granted under the 2017 Stock Plan. During the year ended December 31, 2021, no stock option awards were granted under the 2017 Stock Plan. The Company used the Black Scholes option pricing model to determine the fair value of stock option grants, using the following assumptions during the year ended December 31, 2022.

​

​	​	​	​
Weighted average expected term		3 years
Weighted average volatility		73	%
Weighted average risk-free interest rate		2.81	%
Dividend yield		0	%

​

Schedule of stock-based compensation expenses recorded in the condensed consolidated statements of operations

The following table summarizes stock-based compensation expenses recorded in the condensed consolidated statements of operations (in thousands):

​

​	​	​	​	​	​	​
​		For the Years Ended December 31,
​	​	2022			2021
Cost of Revenue	​	$	47	​	$	56
Sales and marketing expense	​		2,104	​		155
General, and administrative	​	​	191	​	​	1,419
Total stock based compensation expense	​	$	2,342	​	$	1,630

​

Summary of stock option activity under all equity compensation plans

A combined summary of stock option activity for all plans for the years ended December 31, 2022 and 2021 is presented below:

​

​	​	​	​	​	​	​	​	​	​	​
​	​	​	​	​	​	​	Weighted	​	​	​
​	​	​	​	Weighted		​	Average	​	Aggregate
​	​	Number of	​	Average		​	Remaining	​	Intrinsic
​	​	Shares	​	Strike		​	Contractual	​	Value
​		(in thousands)		Price			Life (Years)		(in thousands)
Outstanding at December 31, 2020		1,107	​	$	2.76	​	​		​	​
Granted		—	​	$	—	​	​		​	​
Exercised		(116)	​	$	4.87	​	​		​	​
Forfeited		(226)	​	$	6.45	​	​		​	​
Outstanding at December 31, 2021		765	​	$	1.36	​	4.68	​	$	​
​	​	​	​	​	​	​	​	​	​	​
Granted		200	​	$	6.23	​	​	​		​
Exercised	​	(157)	​	$	0.66	​	​	​	​	​
Forfeited		(15)	​	$	4.18	​	​	​		​
Outstanding at December 31, 2022		793	​	$	2.67	​	5.03	​	$	​
Exercisable at December 31, 2022		557	​	$	1.31	​	3.40	​	$	​

Summary of stock options outstanding under the plans

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Outstanding

​

Weighted average

​

​

​

​

​

​

​

​

​

​

​

​

Number of

​

Remaining

​

​

​

​

​

​

​

​

Weighted Average

​

​

Options

​

Contractual

​

Weighted Average

​

Exercisable Number of

​

Remaining Exercisable

​

Exercisable

Range

(in thousands)

Life (years)

Strike Price

Options (in thousands)

Contractual Life (years)

Strike Price

$0 to $2.00

354

2.31

​

$

0.30

354

2.31

​

$

0.30

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

$2.01 to $4.00

217

5.56

​

$

2.69

187

5.48

​

$

2.65

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

$4.01 to $10.00

222

8.86

​

$

6.45

15

3.23

​

$

8.33

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

793

5.03

​

$

2.67

557

3.40

​

$

1.31

​

Schedule of our unvested stock options

A summary of our unvested stock options as of December 31, 2022 and 2021 and related activity is presented below:

​	​	​	​	​	​
​		Non-vested		​	​
​	​	Shares	​	Weighted
​	​	Under	​	Average
​	​	Option	​	Grant Date
​	​	(in thousands)	​	Fair Value
Non-vested at December 31, 2020		474	​	$	4.35
Granted		—	​		—
Vested		(167)	​		1.93
Forfeited		(212)	​		6.48
Non-vested at December 31, 2021		95	​	$	3.85
Granted		200	​		6.23
Vested		(49)	​		4.12
Forfeited		(9)	​		5.49
Non-vested at December 31, 2022		237	​	$	5.90

​

Schedule of restricted stock award activity under all equity compensation plans

A summary of restricted stock award activity under the 2017 Stock Plan for the years ended December 2022 and 2021 are presented below:

​

​	​	​	​	​	​
​	​	Number of Shares		Weighted Average
​		(in thousands)		Grant Date Fair Value
Outstanding at December 31, 2020		295	​	$	11.53
Granted	​	381	​	$	14.15
Vested		(119)	​	$	10.92
Forfeited		(103)	​	$	12.40
Outstanding at December 31, 2021		454	​	$	13.69
Granted		186	​	$	8.52
Vested		(165)	​	$	12.90
Forfeited	​	(52)	​	$	10.60
Outstanding at December 31, 2022		423	​	$	11.94

​

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for outstanding and exercisable number of stock options.

+ References

No definition available.

+ Details

Name:	zyxi_ScheduleOfOutstandingAndExercisableNumberOfStockOptionsTableTextBlock
Namespace Prefix:	zyxi_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration